Regulatory requirements stipulate that the production of any agents intended for use in human clinical trials must be performed under current Good Manufacturing Practices (cGMP). 1 Retroviral vector ...
Innovation in manufacturing technologies must occur to ensure the availability of gene therapies and cell therapies. The rapid advance of gene and modified cell therapies and growing interest in viral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback